drugset / Trial / NCT01846689

An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease

NCT01846689 ↗

Phase 3 Unknown 30 enrolled Targeted Medical Pharma
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to measure the change in blood values after the administration of an amino acid based erythropoietin stimulating system.

Timeline

Start
2013-06
Primary completion
2013-08
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject ESS Unknown — —